Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-24 @ 11:40 PM
NCT ID:
NCT01722851
Eligibility Criteria:
Inclusion Criteria
1. Patient must meet the criteria for either:
Cohort 1: All patients with a new diagnosis of breast cancer, who are destined to undergo neoadjuvant chemotherapy.
OR Cohort 2: All breast cancer patients who present with metastatic disease, disease recurrence or progression who will receive up-front chemotherapy ± hormonal therapy.
OR Cohort 3: All breast cancer patient who present with metastatic disease who are commencing hormonal therapy only.
2. Patients must be aged 18 years or over.
3. Patients must be able to give written informed consent.
Exclusion Criteria
All patients, who do not fulfil the inclusion criteria mentioned above.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT01722851
Study Brief:
Protocol Section:
NCT01722851